Biomerica (BMRA) said Thursday that its inFoods Irritable Bowel Syndrome test will be marketed by Henry Schein (HSIC) in the US, with the exception of New York State, as part a marketing services arrangement between the two companies.

Henry Schein will market the test to primary care and gastroenterology specialty practices, Biomerica said.

Financial details of the agreement were not disclosed.